The development of functional materials for efficient
protein removal
and antipsychotic drug extraction in biological samples is attracting
great interest. In this study, a nanoscale ethylenediamine-functionalized
chromium-based metal–organic framework (MOF) (MIL-101-ED) was
designed, synthesized, and applied for the one-step removal of proteins
and the extraction of antipsychotic drugs in serum samples. The introduction
of ethylenediamine in the MIL-101 nanoparticle (NP), in which amino
and carbon chains can enhance the hydrogen-bond interaction and π–π
interaction between functionalized MOFs and antipsychotic drugs, i.e.,
risperidone, etc. The antipsychotic drugs were ionized and amino groups
were protonated at pH = 3, due to electrostatic interaction, and the
negatively charged drugs were adsorbed on the surface or even entered
the pores of MOFs. The adsorption efficiencies of the six kinds of
drugs ranged from 80.1 to 101.4%. Owing to the exclusion action, proteins
were excluded from MIL-101-ED and the exclusion rate ranged from 91.9
to 94.0%. Furthermore, MIL-101-ED can be easily regenerated and reused
four times without a significant reduction in the protein exclusion
rate and adsorption capacity. Coupled with high-performance liquid
chromatography–diode array detection (HPLC–DAD) strategy,
the application of MIL-101-ED for extracting the antipsychotic drugs
and their metabolites in serum samples was developed. The recoveries
of antipsychotic drugs and their metabolites in serum ranged from
83.2 to 110.8%, and the related detection limits were all <5.55
ng mL–1. Compared to the traditional extraction
methods, the pretreatment steps of MIL-101-ED have the advantages
of easy operation and reducing the environmental pollution. Here,
we propose that MIL-101-ED, as a kind of restricted access media nanophase
material, can be applied to extract antipsychotic drugs in serum samples.